Showing 3361-3370 of 8675 results for "".
Hidradenitis Suppurativa: A Patient’s Perspective
https://practicaldermatology.com/topics/rare-disease/hidradenitis-suppurativa-a-patients-perspective/27171/Adam Friedman, MD, FAAD, presents a first-hand account of a patient living with hidradenitis suppurativa (HS).A Protocol and Literature Review for Indocyanine Green in the Assessment of Periorbital and Facial Lymphatics
https://practicaldermatology.com/youngmd-connect/resident-resource-center/a-protocol-and-literature-review-for-indocyanine-green-in-the-assessment-of-periorbital-and-facial-lymphatics/24016/Intergenerational Dermatology: Two Generations of Dermatologists Reflect on the Field
https://practicaldermatology.com/topics/general-topics/intergenerational-dermatology-two-generations-of-dermatologists-reflect-on-the-field-2/23937/With Heidi A. Waldorf, MD, and Donald S. Waldorf, MDPhysician Spotlight: Vishal Anil Patel, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-vishal-anil-patel-md/23899/Thick Melanomas: Assessing Prognosis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/thick-melanomas-assessing-prognosis/23685/New data identifies stratified risk based on the thickness of melanomas thicker than 4mm.Slimming the Masseters with Neuromodulator Injections
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/slimming-the-masseters-with-neuromodulator-injections/23648/Demand for this minimally-invasive and effective intervention is growing. Success depends on proper training and administration.Pearls for Managing Rosacea During Home Isolation
https://practicaldermatology.com/topics/acne-rosacea/pearls-for-managing-rosacea-during-home-isolation/23279/Encourage patients to keep up with skincare and prescription regimens and be prepared to offer in-office procedures when appropriate.Eczema Discovery; Ortho Dermatologics, Revision, Alastin Product Launches
https://practicaldermatology.com/topics/practice-management/dermwiretv-eczema-discovery-ortho-dermatologics-revision-alastin-product-launches/18353/Regeneron revealed that Dupixent generated sales of $120M within the first nine months of launch. Researchers have identified a possible treatment for moderate-to-severe atopic dermatitis: IL-22 blockade. Product launches or updates from Revision Skincare, Alastin Skincare, Ortho Dermatologics, andThe Importance of Branding Your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/the-importance-of-branding-your-dermatology-practice/20656/Humphries to Valeant, Restylane Line Expands, 2016 Highlights
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-humphries-to-valeant-restylane-line-expands-2016-highlights/18709/The filler market in the US expands with FDA approval of Galderma's Restylane Refyne and Restalyne Define for the treatment of nasolabial folds in patients over the age of 21. The gels are manufactured with XpresHAn Technology, which allows a range of flexibility and support for varied patient needs